The global unit dose manufacturing market size is expected to reach USD 87.4 billion in 2030 and is projected to grow at a CAGR of 19.0% from 2024 to 2030. In the first half of 2020, the growth of the market was stagnant, but the market started to recover by the end of 2020. It was mainly due to the use of unit doses for the treatment of COVID-19 as it decreases the risk involved while handling and pouring doses from the same bottle.
Unit dose manufacturing has many advantages as the drug can be easily identified, and the formulation of the drug is protected until the moment of administration. If the container is intact and the drug has not been used, it can be redisposed and retrieved without changing its formulation. The most important benefit is that it can be administered in the proper dosage and ensures that the patient does not exceed the prescribed limit.
However, the COVID-19 pandemic has a significant effect on the pharmaceutical market. The first half of the COVID-19 pandemic had slowed growth but by the end of 2020, the market started to recover. The unit dose manufacturing is lucratively used in the current scenario as it reduces the risk of handling and contamination. Also, unit doses are widely used in hospitals for COVID-19 patients to safeguard both patients and healthcare personnel to eliminate the possibility of viral transmission by airborne transmission or direct touch.
Request a free sample copy or view report summary: Unit Dose Manufacturing Market Report
By sourcing, The outsourcing segment accounted for the largest market share of 59.9% in 2023. This growth can be attributed to the increased demand by the customers and small pharma companies.
The solid unit segment accounted for the largest market share of 49.4% in 2023 as it is cost-efficient and simple to use and has a good shelf life.
The independent pharmacies segment accounted for the largest revenue share of over 35.9% in 2023. This growth can be attributed to the different products offered by this sector.
The North America unit dose manufacturing market held the largest revenue share of 47.9% in 2023.
Grand View Research has segmented the global unit dose manufacturing market report based on sourcing, product, end use, and region:
Unit Dose Manufacturing Sourcing Outlook (Revenue, USD Million, 2018 - 2030)
In-house
Outsourcing
Unit Dose Manufacturing Product Outlook (Revenue, USD Million, 2018 - 2030)
Liquid Unit Dose
Solid Unit Dose
Others
Unit Dose Manufacturing End Use Outlook (Revenue, USD Million, 2018 - 2030)
Independent Pharmacies
Long-Term Care Facility
Hospitals
Others
Unit Dose Manufacturing Regional Outlook (Revenue, USD Million 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
India
Japan
China
Latin America
Brazil
Argentina
Mexico
Middle-East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Unit Dose Manufacturing Market
Catalent, Inc
Thermo Fisher Scientific Inc.
Unither
Tapemark
Mikart
RENAISSANCE LAKEWOOD, LLC.
Medical Packaging, Inc.
CordenPharma
American Health Packaging
Cencora, Inc
Amcor PLC
"The quality of research they have done for us has been excellent..."